Fungal infections in cancer patients

Michael Peter Angarone*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

9 Scopus citations


Invasive fungal infections (IFI) have become a leading cause of morbidity and mortality in cancer patients. Infections with these organisms are often difficult to diagnose and treat. Appropriate and timely diagnosis requires a high index of suspicion and invasive procedures, including biopsy, to confirm the diagnosis. Treatment may be difficult, secondary to variable susceptibility and difficulty with exact and specific characterization of the fungal pathogen. The pathogens that are seen range from yeasts to invasive molds. Fortunately newer, noninvasive diagnostic techniques are available to aid in the diagnosis and treatments have become better tolerated and more efficacious.

Original languageEnglish (US)
Pages (from-to)129-155
Number of pages27
JournalCancer Treatment and Research
StatePublished - Jan 1 2015


  • Aspergillosis
  • Candida species
  • Malignancy
  • Mucormycosis

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Fungal infections in cancer patients'. Together they form a unique fingerprint.

Cite this